Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

NCT00005960 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

INDUSTRY

Sponsor class

Conditions

Pain
Prostate Cancer

Interventions

BIOLOGICAL: filgrastim
DRUG: cyclophosphamide
DRUG: docetaxel
DRUG: doxorubicin hydrochloride
PROCEDURE: pain therapy

Sponsor

Amgen